Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Aarthi Chary
IL28B Polymorphism Is Not Associated With HCV Protease Diversity in Patients Co-Infected With HIV and HCV Treated With Pegylated Interferon and Ribavirin
Journal of Medical Virology
Virology
Infectious Diseases
Related publications
The Importance of IL28B Polymorphism in Response to Pegylated Interferon Α and Ribavirin in Chronic Hepatitis Caused by HCV Genotype 1b
Przeglad Gastroenterologiczny
Gastroenterology
Host Genetic Factors and Dendritic Cell Responses Associated With the Outcome of Interferon/Ribavirin Treatment in HIV-1/HCV Co-Infected Individuals
Journal of Clinical & Cellular Immunology
Sustained Virologic Response and IL28B Single-Nucleotide Polymorphisms in Patients With Chronic Hepatitis C Treated With Pegylated Interferon Alfa and Ribavirin.
Acta Biochimica Polonica
Biochemistry
Genetics
Molecular Biology
Correction of Metabolic Disorders in Patients Co-Infected With HIV/HCV
ScienceRise
Dermatological Manifestations of Pegylated Interferon Alfa2a and Ribavirin Combination Therapy in Chronic HCV Patients
Afro-Egyptian Journal of Infectious and Endemic Diseases
Greater Decline in Memory and Global Neurocognitive Function in HIV/hepatitis C Co-Infected Than in Hepatitis C Mono-Infected Patients Treated With Pegylated Interferon and Ribavirin
Journal of NeuroVirology
Virology
Neurology
Cellular
Molecular Neuroscience
Changes in T-Cell Subsets in HIV–HCV-coinfected Patients During Pegylated Interferon-Α2a Plus Ribavirin Treatment
Antiviral Therapy
Infectious Diseases
Pharmacology
NS3 Protease Polymorphism and Natural Resistance to Protease Inhibitors in French Patients Infected With HCV Genotypes 1–5
Antiviral Therapy
Infectious Diseases
Pharmacology
PMO-145 Ethnicity Has No Impact on SVR Rates in Patients With HCV Genotype 3 Treated With Pegylated Interferon and Ribavirin: Abstract PMO-145 Figure 1
Gut
Gastroenterology
